Due to the lack of published raw data and inconsistency of the outcomes reported, the subgroup analysis was restricted, and it was not possible to fully investigate the effects of BRCA1 and BRCA2 pathogenic variants independently and the effect of menopause status on all the reported BC outcomes. Here, BRCA1 is linked to breast cancer.